The obese growth hormone (GH)-deficient dwarf rat: Body fat responses to patterned delivery of GH and insulin-like growth factor-I

Endocrinology

Volumn 137, Issue 5, 1996, Pages 1904-1912

  Clark, R G ^a   Mortensen, D L ^a   Carlsson, L M S ^b   Carlsson, B ^b   Carmignac, D ^c   Robinson, I C A F ^c  

^a GENENTECH INC   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DWARFISM; FAT INTAKE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029923352     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612530     Document Type: Article

References (46)

1. Davidson MB 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131
2. De Boer H, Blok G-J, Van der Veen EA 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
3. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
4. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom X, Isaksson OGP 1993 Treatment of adults with growth hormone deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
5. Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen J-O 1994 Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose LPL activity. Am J Physiol 266:E211-E216
6. Synder DK, Clemmons DR, Underwood LE 1988 Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks. Effects on anabolism, lipolysis and body composition. J Clin Endocrinol Metab 67:54-61
7. Martin RJ, Drewry M, Jewell D, Harris RBS, Young R, Patton JS 1989 Growth hormone treatment reduces total body fat accumulation in Zucker obese rats. Int J Obes 13:327-335
8. Etherton TD, Louveau I, Sorenson MT, Chaudhuri S 1993 Mechanisms by which somatotrophin decreases adipose-tissue growth. Am J Clin Nutr 58:5287-5295
9. Charlton HM, Clark RG, Robinson ICAF, Porter-Goff AE, Cox BS, Bugnon C, Bloch BS 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58
10. Jansson JO, Albertsson-Wikland K, Eden S, Thorngren KG, Isaksson OGP 1982 Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomised rats. Acta Physiol Scand 114:261-265
11. Clark RG, Jansson JO, Isaksson O, Robinson ICAF 1985 Intravenous growth hormone: growth responses to patterned infusions. J Endocrinol 104:53-61
12. Clark RG, Mortensen DL, Carlsson LMS 1995 Insulin-like growth factor-1 and growth hormone (GH) have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine 3:297-304
13. Clark RG, Mortensen D, Carlsson LMS, Carmignac D, Robinson ICAF 1995 Growth responses to patterned GH delivery. Endocrine 3:717-723
14. Clark RG, Chambers G, Lewin J, Robinson ICAF 1986 Automated repetitive microsampling of blood: growth hormone secretion in conscious male rats. J Endocrinol 111:27-35
15. Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR 1992 Effects of recombinant human insulin-like growth factor-1 (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab 75:30-36
16. Carmignac D, Wells T, Carlsson L, Clark R, Robinson I 1992 Growth hormone (GH)-binding protein in normal and GH-deficient dwarf rats. J Endocrinol 135:447-457
17. Abdel El Motal SM, Sharp GWG 1985 Inhibition of glucose-stimulated insulin release by xylazine. Endocrinology 116:2337-2340
18. Renier G, Gaudreau P, Hajjad H, Deslauriers N, Houde NM, Brazeau P 1990 Decreased pituitary growth hormone response to growth hormone-releasing factor in cafeteria-fed rats: dietary and obesity effects, Neuroendocrinology 52:284-290
19. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
20. D'Ercole 1993 Expression of insulin-like growth factor-1 in transgenic mice. Ann NY Acad Sci 692:149-160
21. Clark RG, Robinson ICAF 1985 Growth induced by pulsatile infusion of an amidated fragment of growth hormone releasing factor in normal, GHRF-deficient rats. Nature 314:281-283
22. Tannenbaum GS, Lapointe M, Gurd W, Finkelstein JA 1990 Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin. Endocrinology 127:3087-3095
23. Skottner A, Clark RG, Fryklund L, Robinson ICAF 1989 Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 124: 2519-2526
24. Schemmel R, Mickelsen O, Gill JL 1970 Dietary obesity in rats: body weight and body fat accretion in seven strains of rats. J Nutrition 100:1041-1048
25. Greenspan FS, Li CH, Simpson ME, Evans HM 1949 Bioassay of hypophyseal growth hormone: the tibia test. Endocrinology 45: 455-463
26. Nilson HW, Palmer LS, Kennedy C 1935 Physiological effects of pituitary growth hormone: growth and efficiency of food utilization. Am J Physiol 111:341-351
27. Bauman DE, Vernon RG 1993 Effects of exogenous bovine somatotropin on lactation. Annu Rev Nutr 13:437-461
28. Schoenle E, Zapf J, Humbel R, Froesch E 1985 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 252-253
29. Skottner A, Clark R, Robinson I, Fryklund L 1987 Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats. J Endocrinol 112:123-132
30. Laron Z, Anin S, Klipper AY, Klinger B 1992 Effects of insulin like growth factor on linear growth, head circumference, and body fat in patients with Laron type dwarfism. Lancet 339:1256-1261
31. Matthews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD 1988 Growth enhancement of transgenic mice expressing human insulin-like growth factor 1. Endocrinology 123:2827-2833
32. Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA 1994 Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58-68
33. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
34. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L 1981 Somatomedin-C mediates growth hormone negative feed-back by effects on both the hypothalamus and the pituitary. Science 212: 1279-1281
35. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KGMM, Thorner MO 1993 A low-dose euglycemic infusion of recombinant human insulin-like growth factor-1 rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462
36. Maiter D, Underwood LE, Maes M, Davenport ML, Ketelslegers JM 1988 Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123:1053-1059
37. Isgaard J, Carlsson LMS, Isaksson OGP, Jansson J-O 1988 Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor-1 messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 123:2605-2610
38. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
39. Baumbach WR, Horner DL, Logan JS 1989 The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 3:1199-1205
40. Maiter D, Walker JL, Adam E, Moats-Staats B, Mulumba N, Ketelslegers JM, Underwood L 1992 Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/ binding protein gene expression in rat liver. Endocrinology 130: 3257-3264
41. Moats-Staats BM, Brady JL, Underwood LE, D'Ercole AJ 1989 Dietary protein restriction in artificially reared neonatal rats causes a reduction of insulin-like growth factor-I gene expression. Endocrinology 125:2368-2374
42. Thissen JP, Triest S, Maes M, Underwood LE, Ketelslegers JM 1990 The decreased plasma concentration of insulin-like growth factor-I in protein-restricted rats is not due to decreased numbers of growth hormone receptors on isolated hepatocytes. J Endocrinol 124:159-165
43. Mulumba N, Massa G, Ketelslegers J-M, Maes M 1991 Ontogeny and nutritional regulation of the serum growth hormone binding protein in the rat. Acta Endocrinol 125:409-415
44. Postel-Vinay MC, Durand D, Lopez S, Kayser C, Lavau M 1990 Increased growth hormone binding to liver membranes of obese Zucker rats. Hormone Metab 22:7-11
45. Tauber MT, Du PH, SallerinCaute B, Rochiccioli P, Bastide R 1993 Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 76: 1135-1139
46. Waters DL, Hardy KJ, Danska J, Nickell D, Quails C, Jackson L, Gesundheit N, Watson D, Nightingale S, Koster F, Schade DS A double-blind placebo-controlled randomised clinical trial of growth hormone and IGF-I in AIDS wasting. Program of the 76th Annual Meeting of the Endocrine Society, 1994, Anaheim CA (Abstract 17)